ne of the chemist's key motivations is to explore the forefront of catalysis. In this Account, we describe our laboratory's efforts at one such forefront: the use of DNA as a catalyst. Natural biological catalysts include both protein enzymes and RNA enzymes (ribozymes), whereas nature apparently uses DNA solely for genetic information storage. Nevertheless, the chemical similarities between RNA and DNA naturally lead to laboratory examination of DNA as a catalyst, especially because DNA is more stable than RNA and is less costly and easier to synthesize. Many catalytically active DNA sequences (deoxyribozymes, also called DNAzymes) have been identified in the laboratory by in vitro selection, in which many random DNA sequences are evaluated in parallel to find those rare sequences that have a desired functional ability. Since 2001, our research group has pursued new deoxyribozymes for various chemical reactions. We consider DNA simply as a large biopolymer that can adopt intricate three-dimensional structure and, in the presence of appropriate metal ions, generate the chemical complexity required to achieve catalysis.
Introduction
Deoxyribozymessalso called DNA enzymes or DNAzymess are DNA sequences that catalyze chemical reactions. Our laboratory's studies on deoxyribozymes were initiated in 2001, when we began in vitro selection experiments seeking ligation of two RNA substrates. Since then, we have published many deoxyribozyme manuscripts, most on RNA ligation but some on ligation of non-RNA oligonucleotide substrates 23, 24 and a growing number on reactions of substrates that are not oligonucleotides at all. [25] [26] [27] [28] This Account describes the motivations and logic behind many of our previous efforts, as well as our ongoing work and likely future directions with deoxyribozymes.
Why Pursue DNA as an Artificial Catalyst?
Of the three natural biopolymers, DNA, RNA, and proteins, only the last two are known to have evolved directly for catalysis. Why, then, would anyone want to pursue DNA as an artificial catalyst? Instead, why not just look to RNA or proteins?
The nucleic acids DNA and RNA together have key practical advantages relative to proteins, for example, regarding both the size of sequence space that must be searched (for an oligomer of length n, 20 n for proteins is much larger than 4 n for DNA/RNA) and the simplicity of oligonucleotide synthesis (which lacks the challenges inherent to protein expression). If the catalytic functions of DNA/RNA are useful, which is ultimately an empirical question, then the practical advantages of nucleic acids relative to proteins will allow more efficient and simpler identification and application of new catalysts. In the direct comparison of DNA to RNA, DNA is much more stable, less costly, and easier to synthesize. Of course, none of these advantages of DNA are important if the catalytic repertoire of DNA is restricted to uninteresting reactions. Therefore, in our efforts with deoxyribozymes, we have sought new catalytic activities, with an eye toward probing the limits of DNA catalysis. The motivation to pursue deoxyribozymes can also be understood from a different direction, by considering the fundamental chemical requirements for building an effective biopolymeric catalyst. Nature has given us proteins, which adopt complex three-dimensional structures and position a variety of functional groups to enable catalytic mechanisms. Nature has also given us ribozymes, which can form intricate 3D structures despite having only four rather similar monomers. Judicious use of metal ions and acid/base interactions equips ribozymes with significant chemical tools for catalysis, even if ribozymes are not quantitatively as good as proteins (and the jury is still out on how good RNA can actually be 29 ) . DNA is very similar to RNA in all of these aspects, and DNA additionally has all of the key advantages as mentioned above. Therefore, expanding the frontier of catalysis by studying deoxyribozymes is a potentially high-reward endeavor.
Why Pursue RNA Ligation as the Target Reaction?
The immediate practical motivation for our initial decision to pursue deoxyribozymes that ligate RNA was the desire for improved RNA ligation catalysts. Since 1992, the principal method for ligating two RNA substrates has been "splint ligation", which uses T4 DNA ligase to join two RNA substrates held together by a complementary DNA splint. 30, 31 Although splint ligation has certainly been successful in many cases, thereby enabling synthesis of large RNAs that incorporate sitespecific modifications for structure-function studies, the method has well-known idiosyncrasies. For example, the ligation efficiency for two particular RNA sequences (especially for large RNAs or those that have considerable secondary structure) is difficult to predict without simply preparing the two substrates and attempting the splint ligation. Preparing large RNA substrates for these tests is not always trivial. In 2001 at the outset of our efforts, we thought, "wouldn't it be great if the DNA splint can simultaneously be the ligation catalyst?" Perhaps using a deoxyribozyme to join two RNAs would be more effective than splint ligation, at least in some cases. Regardless of immediate practical utility, a second objective for pursuing DNA-catalyzed RNA ligation was simply to learn more about the catalytic properties of DNA, both in terms of basic selection principles and in terms of reactions that can be catalyzed. The first deoxyribozyme was reported in 1994 for cleavage of an RNA phosphodiester linkage embedded within a DNA oligonucleotide substrate. 32 Between 1994 and 2001, many additional RNA-cleaving deoxyribozymes were reported, all of which catalyze the same cleavage reaction (including within all-RNA substrates), 33 but DNA catalysis of other reactions was and still is rare. 34 33, 43 In contrast, for RNA ligation a variety of reaction chemistries can be envisioned, including many with non-natural functional groups. We restricted ourselves to functional group combinations that are readily obtained without undue effort, to ensure the widest utility for any resulting deoxyribozymes. In practice, this limited us to two substrate combinations ( Figure 1 ): 2′,3′-cyclic phosphate with 5′-hydroxyl and 3′-hydroxyl with 5′-triphosphate. In both cases, this led directly to questions of chemical selectivity that must be addressed during the in vitro selection process. In Vitro Selection Strategy. Inspired by previous approaches to RNA-cleaving deoxyribozymes, we devised the general in vitro selection strategy for RNA ligation depicted in Figure 2 . To initiate the selection process, a "random pool" DNA oligonucleotide is prepared by solid-phase synthesis, incorporating an N 40 
RNA Ligation with 2′,3′-Cyclic Phosphate Substrates
Our initial effort used the RNA substrate combination shown in Figure 1A . 1 The cyclic phosphate substrates are themselves the products of RNA cleavage, either by ribonucleases such as RNase A or by deoxyribozymes. We used the well-known 10-23 deoxyribozyme 44 to prepare the RNA substrate that has a 2′,3′-cyclic phosphate. Then, as our first in vitro selection target, we sought RNA ligation using the selection strategy of Figure 2 . Our initial design placed four unpaired RNA nucleotides of each substrate at the ligation junction, with all remaining nucleotides of each RNA substrate forming Watson-Crick base pairs with the deoxyribozyme "binding arms" ( Figure 3A ). For brevity, we designated the two RNA substrates as the "left-hand" and "right-hand" substrates, or L and R, as marked in Figure 3A . Four nucleotides were left unpaired on both L and R because active deoxyribozyme sequences might require non-Watson-Crick interactions with these nucleotides. Alternatively, the selection process could favor deoxyribozyme sequences that create canonical DNA:RNA base pairs. The outcome of this initial selection effort was a set of Mg 2+ -dependent deoxyribozymes that had two key features. 1 First, all new RNA linkages were non-native 2′-5′ rather than native 3′-5′, formed by opening of the cyclic phosphate with the 3′-oxygen rather than the 2′-oxygen serving as the leaving group. (Assignments of 2′-5′ rather than native 3′-5′ linkages were made by straightforward biochemical approaches, such as assaying the ligation products with a deoxyribozyme that is selective for cleaving 3′-5′ linkages and measuring the half-life for uncatalyzed cleavage when the RNA product is in a DNA:RNA duplex; the 2′-5′ linkages are much more labile in this context.) Second, each deoxyribozyme required several specific RNA nucleotide identities on either side of the ligation junction. Our subsequent efforts to identify deoxyribozymes that function with the cyclic phosphate RNA substrate combination were designed to understand and ideally control the ligation junction connectivity and substrate sequence requirements.
In one set of efforts, we retained Mg 2+ as the divalent metal ion cofactor and changed the selection design by reducing the random region length, 2,3 by reselecting initially identified sequences for improved catalysis, 4 or by changing the base-pairing status of the RNA nucleotides near the ligation site. 5 In all cases, our principal interest was the regioselectivity of the cyclic phosphate ring-opening reaction that forms either 2′-5′ or 3′-5′ linkages. Surprisingly, again only nonnative 2′-5′ linkages were created. We do not yet have a mechanistic explanation for this uniform DNA-catalyzed synthesis of non-native linkages with Mg 2+ and the cyclic phosphate RNA substrate combination.
In a second set of efforts, we performed selections using Zn 2+ rather than Mg
2+
. We were excited to find several deoxyribozymes that create native 3′-5′ linkages, along with deoxyribozymes that form a variety of other linkages. 6 Importantly, each new deoxyribozyme creates just one kind of linkage. We then modified the selection process (e.g., by changing the number of unpaired RNA nucleotides near the ligation junction) and found additional deoxyribozymes that also create native 3′-5′ linkages. 7 However, enough specific RNA nucleotides were required near the ligation junction that these deoxyribozymes would not be general for ligating a wide variety of RNA sequences. More work remains to solve this problem. In addition, we do not yet know the reason why changing the metal ion cofactor from Mg 2+ to Zn 2+ leads to different regioselectivities during the 2′,3′-cyclic phosphate opening reaction.
RNA Ligation with 5′-Triphosphate Substrates
Soon after we began efforts with the cyclic phosphate substrates, we also examined the 5′-triphosphate RNA substrate combination shown in Figure 1B . Initially, we used the same arrangement of RNA substrates and deoxyribozyme as in Figure 3A , merely replacing the functional groups on both substrates at the intended ligation site. 8, 9 We originally expected that either the 2′-OH or 3′-OH of the L substrate would attack the 5′-triphosphate of the R substrate, forming a linear RNA linkage (either 2′-5′ or 3′-5′). However, the attacking nucleophile was actually a 2′-OH group from within L, leading to 2′,5′-branched RNA (Figure 4 ). For at least one of the resulting deoxyribozymes, L and R could be part of the same RNA We also sought linear native 3′-5′ RNA linkages by moving the ligation site to within a DNA:RNA duplex region. 13 The rationale was that native 3′-5′ linkages are known to be more stable than non-native 2′-5′ linkages in this structural context; this relative stability should be felt to at least some extent in the ligation transition state, leading to selectivity.
While this strategy proved successful and the resulting deoxyribozymes indeed created almost entirely 3′-5′ native linkages, too many specific RNA substrate nucleotides were required for practical utility. We sought to exploit the ability of deoxyribozymes to create 2′,5′-branched and lariat RNA. The 7S11 deoxyribozyme requires base pairing with every nucleotide of the two RNA substrates except the branch-site nucleotide ( Figure 5A ). This suggested significant generality for many RNA substrate sequences, and indeed this was so. 14 Separately, one of the deoxyribozymes found during development of the 8-17
selection pressure (6CE8) 11 was shown to be useful for creating branched RNA with any branch-site nucleotide, 16 which is one of the only nucleotides whose identity is restricted for 7S11. We also showed that another deoxyribozyme (6BX22)
can be used for one-step synthesis of lariat RNAs directly related to biological sequences, 17 and we developed a twostep ligation route to lariats that cannot be made efficiently in one step. 18 We examined the origin of the branch-site adenosine preference of 7S11 by performing selection experiments using the 3HJ architecture where the branch-site nucleotide was U rather than A. 19 Although the DNA pool never had access to branchsite A during the selection process, the resulting deoxyri- 
Applications of Deoxyribozymes that Ligate RNA
We used branched RNAs formed by deoxyribozymes to enable biochemical studies that would otherwise have been essentially impossible. 20, 22 These studies investigated biochemical pathways that are either known to involve branched RNA 20 or controversially proposed to do so 22 (in the latter case, our data support the conclusion that branched RNA is not actually involved). However, the number of such experiments that make use of synthetic branched RNA is smaller than we had originally hoped. Despite over two decades of literature statements that synthetic access to branched RNAs is a major roadblock to biochemical experiments, we have found that devising meaningful experiments using synthetic branches is actually rather difficult. Many biochemical processes related to branched RNA (such as pre-mRNA splicing)
are highly orchestrated, and a separately synthesized branch cannot be readily integrated into most of the relevant biochemical assays.
We also used deoxyribozymes to enable a new strategy for site-specific RNA labeling: DECAL, or deoxyribozyme-catalyzed labeling ( Figure 7) . 21 In DECAL, a specific 2′-OH nucleophile on the large "target" RNA attacks the 5′-triphosphate electrophile of a second "tagging" RNA, which carries a biophysical label (e.g., fluorescein or biotin) at its second nucleotide position.
Using DECAL, we could readily place the fluorescence resonance energy transfer (FRET) dyes fluorescein and tetramethylrhodamine onto two specific nucleotides of the 160- Deoxyribozymes that form a three-helix-junction (3HJ) architecture with their RNA substrates: (A) The 7S11 deoxyribozyme, which forms 2′,5′-branched RNA. 10, 14 The related 10DM24 deoxyribozyme has a similar architecture. 19 (B) Conversion of 10DM24 to use GTP as a small-molecule substrate along with a shortened oligonucleotide cofactor (R ∆ ). 25 (C) Use of two molecules of GTP as substrate and cofactor, along with an oligonucleotide cofactor (R ∆∆ ).
FIGURE 6.
Two general deoxyribozymes for RNA ligation using the 5′-triphosphate substrate combination. 12 FIGURE 7. Strategy for deoxyribozyme-catalyzed labeling (DECAL) of an RNA target. 21 The labeled tagging RNA is prepared (top) and attached to the target RNA using the 10DM24 deoxyribozyme (bottom).
Deoxyribozymes Silverman nucleotide P4-P6 RNA domain, thereby enabling a straightforward FRET folding experiment for this RNA.
General Themes from RNA-Ligating Deoxyribozymes
The several years since our first publication on RNA-ligating deoxyribozymes 1 have provided some perspective, which allows us to identify four general themes that have emerged from these efforts. 
Remaining Efforts Needed for DNACatalyzed RNA Ligation
Our efforts with DNA-catalyzed RNA ligation have left several unanswered questions. First, using the cyclic phosphate substrate combination of Figure 1A , can one find a general set of RNA-ligating deoxyribozymes for creation of native 3′-5′
linkages? So far, the Zn 2+ -dependent deoxyribozymes have come close, 7 but their substrate sequence generality is poor.
Second, using the 5′-triphosphate substrate combination of 
Ligation with DNA (rather than RNA) Substrates
Follow-up efforts have focused on DNA rather than RNA as one or both of the ligation substrates. When the L substrate is DNA, the nucleotide with the 2′-OH nucleophile is still RNA.
When the R substrate is DNA, the activated 5′-terminus is adenylated rather than triphosphorylated. 46 We have obtained deoxyribozymes that synthesize branched RNA-DNA conjugates (L RNA, R DNA) 23 as well as entirely branched DNA molecules (L and R both DNA). 24 As is the case for branched RNA formation, further experiments are needed to obtain the best DNA catalysts.
DNA Catalysis beyond Oligonucleotide Ligation
Our more recent efforts have turned to investigating DNAcatalyzed reactions other than oligonucleotide ligation. Engineering a Selective Small-Molecule Binding Site.
An important challenge for deoxyribozymes is use of small molecules rather than oligonucleotides as substrates. Because 7S11 and 10DM24 have a well-defined 3HJ architecture that spatially juxtaposes the nucleophilic 2′-OH and electrophilic 5′-triphosphate ( Figure 5A ), we were curious whether such a deoxyribozyme could be rationally engineered to use a mononucleotide 5′-triphosphate (NTP) as a small-molecule substrate.
To explore this, we provided GTP as a substrate to 10DM24, along with an oligonucleotide that corresponds to the remaining portion of R (R ∆ ; Figure 5B ). 25 We were pleased to find that 10DM24 indeed retains catalytic activity, albeit with a relatively high concentration of GTP (K d,app >1 mM). We found that GTP can be replaced with ATP or its more strongly hydrogenbonding analogue 2,6-diaminopurine ribonucleoside triphosphate (DTP), as long as Watson-Crick base pairing is maintained by changing the corresponding 10DM24 nucleotide from C to T. We also found that GTP can be simultaneously a cofactor and a substrate when two nucleotides are omitted from the R oligonucleotide (R ∆∆ ; Figure 5C ). Because these efforts were enabled by the oligonucleotide nature of the original full-length R substrate, experiments to use non-NTP small-molecule substrates will need to involve more sophisticated design strategies. Diels-Alder Deoxyribozymes. Because DNA lacks the 2′-OH group of RNA on every nucleotide, DNA might be less catalytically active than RNA. 47 This concern is valid only to the extent that (i) DNA adopts a meaningfully smaller variety of tertiary structures than RNA, and (ii) DNA's catalytic mechanisms are impeded by the absence of 2′-OH groups. However, many studies with aptamers indicate that DNA has no systematic deficiency relative to RNA in target-binding ability. 48 To allow a direct catalytic comparison between DNA and RNA, we used in vitro selection to identify deoxyribozymes for the Diels-Alder reaction between anthracene and maleimide substrates (Figure 8 ). 28 The resulting deoxyribozymes were essentially equivalent to the previously found ribozymes 49 in terms of catalytic parameters (e.g., k cat ) and rate enhancement, suggesting that DNA and RNA are equally efficient catalysts for this C-C bond-forming reaction. Of course, it is inherently impossible to identify "all" nucleic acid enzymes from these relatively large sequence spaces; N 40 random pools have 4 40 ≈ 10 24 possible sequences, whereas 10 14 molecules are used to initiate the selection process. Nevertheless, when Diels-Alder catalysis was sought from DNA and independently from RNA, both kinds of nucleic acids provided sequences with comparable activities. Future efforts should explore a wider range of DNA-catalyzed chemical reactions, especially those that might more strongly benefit from a catalyst than the Diels-Alder reaction. DNA-Hydrolyzing Deoxyribozymes. We have recently identified several deoxyribozymes that hydrolyze DNA phosphodiester linkages with high sequence selectivities. 50 Such deoxyribozymes are markedly distinct from other deoxyribozymes that oxidatively cleave DNA. 51 While it is too early to know how useful DNA-hydrolyzing deoxyribozymes will be, these catalysts have significant practical promise. Fulfilling this promise will require developing the ability to cleave many DNA sequences, especially in the context of double-stranded substrates such as plasmid DNA. Seeking Protein Side Chains As Substrates. Finally, we have begun to explore DNA-catalyzed reactions of amino acid side chains. 26 We identified a deoxyribozyme, Tyr1, that creates a nucleopeptide linkage between a tyrosine side chain and the 5′-terminus of an RNA oligonucleotide ( Figure 9 ).
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Tyr1 adopts the 3HJ architecture, which positions the tyrosine -OH nucleophile close to the 5′-triphosphate electrophile. In a parallel set of selection experiments, neither serine nor lysine at the 3HJ intersection was successful as a nucleophile. However, we have recently shown that expanding the single 
What's Next for Deoxyribozymes?
Now is an appropriate time to speculate on what the next period of deoxyribozyme research might reveal, both in our laboratory and elsewhere. I anticipate that exploration of DNA catalysis will be particularly interesting and useful in three related research areas: Area 1: New DNA-Catalyzed Reactions. Deoxyribozymes may be most widely useful if they are not largely restricted to oligonucleotide substrates. Small-molecule substrates should be explored much more thoroughly. Site-selectivity in chemical reactivity of two or more functional groups on a small molecule should be evaluated, and a broad range of chemical reactions should be examined. A second class of interesting substrates is proteins. Our current efforts have examined "test" substrates that have only 1-3 amino acids, seeking to learn the capabilities of deoxyribozymes that function with amino acid side chains along with the basic rules for identification of these catalysts. We now need to bring in substrates that are free full-length proteins. For both small-molecule and protein substrates, exploiting explicit aptamer domains to assist catalysis may be a useful approach.
Area 2: Investigation of Deoxyribozyme Structures and Mechanisms. The in vitro selection process demands catalytic activity but not any particular DNA structure or catalytic mechanism. Our understanding of deoxyribozyme structures and mechanisms lags substantially behind that for ribozymes and protein enzymes. Considering that no highresolution structural information is available for any active deoxyribozyme, 52 investigating both structures and mechanisms of DNA catalysts should be a fruitful area for future studies. Area 3: Applications of Deoxyribozymes. Finally, one of the key motivations to pursue new catalysts is to enable applications that require such catalysts. Further development of deoxyribozymes will likely be guided by the need for certain kinds of catalysis. For example, our ongoing work with DNAcatalyzed DNA hydrolysis is promising because developing new catalysts for this reaction is challenging, and DNA as a catalyst interacts quite naturally and sequence-specifically with DNA as a substrate. When considering other substrates such as small molecules and proteins, we hope that deoxyribozymes can be applied for difficult chemical transformations such as selective amino acid side chain modification.
In summary, our investigations of deoxyribozymes since 2001 have generated scientific excitement on several fronts. Our efforts began with DNA catalysis using RNA oligonucleotide substrates. Of course, DNA can interact well with a wide variety of substrates, including small-molecule compounds and proteins. We have adopted the broader view of DNA as an informational biopolymer that, like proteins and RNA, has latent catalytic abilities that can be coaxed with many substrates via appropriate in vitro selection designs and pressures, along with occasional assistance from serendipity. One of the reasons this research field is so exciting is the opportunity to discover new kinds of chemistry. It should be very interesting to see how the scope of DNA-catalyzed chemistry continues to expand in future experiments. 
